Market Tracker

04/24 6:02pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

4.94
Delayed Data
As of Apr 24
 -0.07 / -1.40%
Today’s Change
4.12
Today|||52-Week Range
6.54
-10.83%
Year-to-Date

Today’s Trading

Previous close5.01
Today’s open4.93
Day’s range4.93 - 5.09
Volume93,596
Average volume (3 months)153,624
Market cap$222.2M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+43.83%
Earnings growth (this year)+17.03%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+349.95%
P/E ratioNM
Price/Sales26.57
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GALEGalena Biopharma Inc+0.02+1.40%
MDGNMedgenics Inc-0.15-1.64%
NAVBNavidea Biopharmaceu...-0.02-1.32%
XENEXenon Pharmaceutical...-0.10-0.68%
Data as of 4:02pm ET, 04/24/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$8.4M
Annual profit (last year)-$36.7M
Net profit margin-435.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts